Nephrostomies in obstructive uropathy; how should hormone resistant prostate cancer patients be managed and can we predict who will benefit?

Prostate Cancer and Prostatic Diseases

Volumn 9, Issue 1, 2006, Pages 42-44

  Harris, Mark R E ^a,b   Speakman, M J ^a  

^a MUSGROVE PARK HOSPITAL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Hormone; Nephrostomy; Obstructive uropathy

Indexed keywords

HORMONE;

AGED; ARTICLE; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROSTOMY; OBSTRUCTIVE UROPATHY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; NEPHROSTOMY, PERCUTANEOUS; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; URETERAL OBSTRUCTION;

EID: 33644921251     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500858     Document Type: Article

References (11)

1. Paul AB, Love C, Chisholm GD. The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer. Br J Urol 1994; 74: 642-645.
2. Markowitz DM, Wong KT, Laffey KJ, Bixon R, Nagler HM, Martin EC. Maintaining quality of life after palliative diversion for malignant ureteral obstruction. Urol Radiol 1989; 11: 129-132.
3. Colombel M, Mallame W, Abbou CC. Influence of urological complications on the prognosis of prostate cancer. Eur Urol 1997; 31: 21-24.
4. BAUS. Guidelines for the Management of Metastatic Prostate Cancer 2005.
5. Dowling RA, Carrasco CH, Babaian RJ. Percutaneous urinary diversion in patients with hormone-refractory prostate cancer. Urology 1991; 37: 89-91.
6. Hamdy FC, Williams JL. Use of dexamethasone for ureteric obstruction on advanced prostate cancer: Percutaneous nephrostomies can be avoided. Br J Urol 1995; 75: 782-785.
7. Lau MW, Temperley DE, Mehta S, Johnson RJ, Barnard RJ, Clarke NW. Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Urol 1995; 76: 565-569.
8. Van Dyke AH, Van Nagell JR. The prognostic significance of ureteral obstruction in patients with recurrent carcinoma of the cervix uteri. Surg Gynaecol Obstetr 1975; 141: 371-373.
9. Chiou RK, Chang WY, Horan JJ. Ureteral obstruction associated with prostate cancer: The outcome after percutaneous nephrostomy. J Urol 1990; 143: 957-959.
10. Fallon B, Olney L, Culp DA. Nephrostomy in cancer patients: To do or not to do? Br J Urol 1980; 52: 237-242.
11. Sandhu DP, Mayor PE, Sambrook PA, George NJ. Outcome and prognostic factors in patients with advanced prostate cancer and obstructive uropathy. Br J Urol 1992; 70: 412-416.